China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

Beijing’s action against clothing maker PVH and biotech company Illumina underlines risk created by trade tensions ...

Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of ...

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Market OverviewThe Global Carrier Screening Market is a genetic testing process that determines whether an individual carries ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

Stellaromics, a start-up that uses multiomics technology to help researchers understand the spatial organization of cells and tissues, has raised $80 million in a series B financing. Catalyst4, a ...

Pacific Biosciences of California, Inc. ( NASDAQ: PACB) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Todd Friedman - Senior Director, Finance and Investor Relations Christian Henry - ...

Bezos formally departed from his leadership role at Amazon in 2021, but his fingerprints remain on the company to this day through its continued innovation and constant growth. Hi ...

Illumina, Inc. (NASDAQ:ILMN – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Wednesday after Morgan Stanley lowered their price target on the stock from $150.00 to ...